Search Results
Article
Economic impact of alvimopan considering varying definitions of postoperative ileus
November 01, 2015
Article
Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients
June 01, 2015
Article
Factor VIII alloantibody inhibitors: Cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment
May 01, 2015
Article
Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected aspergillus invasive fungal infections in China
May 01, 2015
Article
Budgetary impact on a U.S. health plan after adopting umeclidinium/vilanterol (UMEC/VI) for the management of moderate-to-severe COPD
April 07, 2015
Article
Treatment interruptions and regimen changes in first-generation vs. second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia
April 01, 2015
Article
Treatment interruption and regimen change in first-generation versus second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia
April 01, 2015
Article
Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs
February 01, 2015